126 related articles for article (PubMed ID: 2725797)
1. Clinical relevance of lysozyme in the faeces.
Hemrika MH; Costongs GM; Engels LG; Bos LP; Janson PC; Flendrig JA
Neth J Med; 1989 Apr; 34(3-4):174-81. PubMed ID: 2725797
[TBL] [Abstract][Full Text] [Related]
2. [Lysozyme in children with acute and chronic inflammatory intestinal diseases].
Dick W; Braun OH; Nagel W
Padiatr Padol; 1985; 20(2):143-50. PubMed ID: 3991222
[TBL] [Abstract][Full Text] [Related]
3. Fecal pyruvate kinase: a potential new marker for intestinal inflammation in children with inflammatory bowel disease.
Czub E; Herzig KH; Szaflarska-Popawska A; Kiehne K; Socha P; Woś H; Kamińska B; Błaszczyński M; Cichy W; Bała G; Brodzicki J; Grzybowska-Chlebowczyk U; Walkowiak J
Scand J Gastroenterol; 2007 Oct; 42(10):1147-50. PubMed ID: 17852864
[TBL] [Abstract][Full Text] [Related]
4. Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome.
Silberer H; Küppers B; Mickisch O; Baniewicz W; Drescher M; Traber L; Kempf A; Schmidt-Gayk H
Clin Lab; 2005; 51(3-4):117-26. PubMed ID: 15819166
[TBL] [Abstract][Full Text] [Related]
5. Detection of inflammatory markers in stools from patients with irritable bowel syndrome and collagenous colitis.
Lettesjö H; Hansson T; Peterson C; Ung KA; Ringström G; Abrahamsson H; Simrén M
Scand J Gastroenterol; 2006 Jan; 41(1):54-9. PubMed ID: 16373277
[TBL] [Abstract][Full Text] [Related]
6. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation.
Kane SV; Sandborn WJ; Rufo PA; Zholudev A; Boone J; Lyerly D; Camilleri M; Hanauer SB
Am J Gastroenterol; 2003 Jun; 98(6):1309-14. PubMed ID: 12818275
[TBL] [Abstract][Full Text] [Related]
7. [Increased IgE-type antibody response to food allergens in irritable bowel syndrome and inflammatory bowel diseases].
Mekkel G; Barta Z; Ress Z; Gyimesi E; Sipka S; Zeher M
Orv Hetil; 2005 Apr; 146(17):797-802. PubMed ID: 17918636
[TBL] [Abstract][Full Text] [Related]
8. Multigene analysis can discriminate between ulcerative colitis, Crohn's disease, and irritable bowel syndrome.
von Stein P; Lofberg R; Kuznetsov NV; Gielen AW; Persson JO; Sundberg R; Hellstrom K; Eriksson A; Befrits R; Ost A; von Stein OD
Gastroenterology; 2008 Jun; 134(7):1869-81; quiz 2153-4. PubMed ID: 18466904
[TBL] [Abstract][Full Text] [Related]
9. An initial report of sleep disturbance in inactive inflammatory bowel disease.
Keefer L; Stepanski EJ; Ranjbaran Z; Benson LM; Keshavarzian A
J Clin Sleep Med; 2006 Oct; 2(4):409-16. PubMed ID: 17557469
[TBL] [Abstract][Full Text] [Related]
10. Serum lysozyme in inflammatory bowel disease.
Dobbins JW; Binder HJ; Spiro HM; Finch SC
Gastroenterology; 1976 Mar; 70(3):469-71. PubMed ID: 1248707
[TBL] [Abstract][Full Text] [Related]
11. [Lysozyme in the differential diagnosis of infections].
Dick W
Med Klin; 1981 May; 76(10):276-8. PubMed ID: 7231322
[No Abstract] [Full Text] [Related]
12. Enzymes in feces: useful markers of chronic inflammatory bowel disease.
Angriman I; Scarpa M; D'Incà R; Basso D; Ruffolo C; Polese L; Sturniolo GC; D'Amico DF; Plebani M
Clin Chim Acta; 2007 May; 381(1):63-8. PubMed ID: 17368600
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
[TBL] [Abstract][Full Text] [Related]
14. Serum lysozyme levels in inflammatory bowel disease.
Manier JW; Roberts RC; Zais DP
Am J Gastroenterol; 1977 Mar; 67(3):245-8. PubMed ID: 868843
[TBL] [Abstract][Full Text] [Related]
15. Letter: Serum lysozyme in inflammatory bowel disease.
Belaiche J; Vesin P; Cattan D; Zittoun J; Bernier JJ
Gastroenterology; 1976 Apr; 70(4):633-4. PubMed ID: 1254148
[No Abstract] [Full Text] [Related]
16. Laboratory evaluation of inflammatory bowel disease.
Wong A; Bass D
Curr Opin Pediatr; 2008 Oct; 20(5):566-70. PubMed ID: 18781120
[TBL] [Abstract][Full Text] [Related]
17. [Lysozyme: basic facts and diagnostic importance].
Dick W
Fortschr Med; 1982 Jul; 100(26):1230-4. PubMed ID: 7118031
[TBL] [Abstract][Full Text] [Related]
18. Faecal calprotectin: a new marker for Crohn's disease?
Wassell J; Dolwani S; Metzner M; Losty H; Hawthorne A
Ann Clin Biochem; 2004 May; 41(Pt 3):230-2. PubMed ID: 15117438
[TBL] [Abstract][Full Text] [Related]
19. Serum and faecal lysozyme in inflammatory bowel disease.
Klass HJ; Neale G
Gut; 1978 Mar; 19(3):233-9. PubMed ID: 631644
[TBL] [Abstract][Full Text] [Related]
20. The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis--how much is irritable bowel syndrome?
Burgmann T; Clara I; Graff L; Walker J; Lix L; Rawsthorne P; McPhail C; Rogala L; Miller N; Bernstein CN
Clin Gastroenterol Hepatol; 2006 May; 4(5):614-20. PubMed ID: 16630762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
